Evidence Hub

Metabolomic insights into late-life depression: a systematic review

Gao Y, Hu JZ, Wen ZP, Dong T, Du XZ, Liu ZF, Liu S

BMC geriatrics, 2025

4 citations

Abstract

Late-life depression (LLD) is a prevalent mental health issue that significantly impacts the quality of life in the elderly population. In recent years, metabolomics has emerged as a novel research tool, offering fresh insights into the molecular mechanisms underlying LLD. This systematic review synthesizes metabolomic studies from January 2004 to March 2024, aiming to identify differential metabolites, explore diagnostic and predictive potential, and investigate aberrant metabolic pathways in LLD. A total of 12 relevant studies were included, revealing differential metabolites such as amino acids and fatty acids, as well as associated metabolic pathways. The study's findings provide insights into the prediction and diagnosis of LLD, highlighting the multifaceted metabolic disturbances associated with the condition. By synthesizing existing literature, we highlight the importance of metabolomic research in identifying biomarkers for LLD and potential therapeutic targets, addressing current gaps in understanding the pathophysiology of this condition.

How strong is the evidence?

Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free